IP Verse

Hopfner, Sebastian Analysis

LAW FIRM ANALYSIS

Latest European patent oppositions filed by Hopfner, Sebastian

Patent:
EP4023755
Title:
Artificial Nucleic Acid Molecules For Improved Protein Expression
Applicant:
CUREVAC SE
Opposition Date:
2023-12-06
Patent:
EP4066819
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS SA
Opposition Date:
2023-11-30
Patent:
EP3708668
Title:
Artificial Nucleic Acid Molecules For Improved Protein Expression
Applicant:
CUREVAC SE
Opposition Date:
2023-04-27
Patent:
EP2611467
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
NOVARTIS AG
Opposition Date:
2023-04-18
Patent:
EP3692065
Title:
Igg1 Fc Mutants With Ablated Effector Functions
Applicant:
CILAG GMBH INTERNATIONAL
Opposition Date:
2022-11-16
Patent:
EP3283125
Title:
Lyophilization Of Rna
Applicant:
CUREVAC MANUFACTURING GMBH
Opposition Date:
2022-09-29
Patent:
EP3718565
Title:
Respiratory Virus Vaccines
Applicant:
MODERNATX, INC.
Opposition Date:
2022-09-23
Patent:
EP3325502
Title:
New Species Of Tobamovirus
Applicant:
NUNHEMS B.V.
Opposition Date:
2021-03-16
Patent:
EP3078667
Title:
Formulation Of Boronic Acid Compounds
Applicant:
THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Opposition Date:
2019-08-20

Top clients of Hopfner, Sebastian filing patent oppositions

Company:
BIONTECH SE
Count:
5
Company:
DR. REDDY'S LABORATORIES LTD./ BETAPHARM ARZNEIMITTEL GMBH
Count:
1
Company:
ENZA ZADEN BEHEER B.V.
Count:
1
Company:
HOPFNER, SEBASTIAN
Count:
1
Company:
ZWICKER SCHNAPPAUF & PARTNER PATENTANWALTE PARTG MBB
Count:
1